|
|
Suppliers for
Cidofovir
|
Properties | CAS |
113852-37-2 | Formula |
C8H14N3O6P |
|
|
13 Registered suppliers
More details are to be found here
More details are to be found here
Molecular Formula: C8H14N3O6P Molecular Weight: 279.187021 HS Code: 2933599550
More details are to be found here
Molecular Formula: C8H14N3O6P Molecular Weight: 279.187021 HS Code: 2933599550
More details are to be found here
More details are to be found here
More details are to be found here
More details are to be found here
Description : Cidofovir is inhibitory to CMV plaque formation even when added to the cells at 48 hr post infection with IC50 of 0.9 μg/mL for Davis and 1.6 μg/mL for AD-169 strains,respectively. - Molecular Weight :279.19
- Boiling Point :609.5±65.0°C (Predicted)
- Melting Point :260°C (dec.)
- Purity :≥98% by HPLC
Molecular Formula : C8H14N3O6P Canonical SMILES : C1=CN(C(=O)N=C1N)CC(CO)OCP(=O)(O)O InChI : InChI=1S/C8H14N3O6P/c9-7-1-2-11(8(13)10-7)3-6(4-12)17-5-18(14,15)16/h1-2,6,12H,3-5H2,(H2,9,10,13)(H2,14,15,16)/t6-/m0/s1 InChIKey : VWFCHDSQECPREK-LURJTMIESA-N Solubility : Soluble in Deionized Water (≥5 mg/mL, Warmed) Appearance : Powder Storage : Store at -20°C Synonyms : Vistide; HPMPC; (S)-HPMPC; Cidofovir anhydrous; GS-504; GS 504; GS504; (S)-1-(3-Hydroxy-2-phosphonomethoxypropyl)cytosine; (S)-(((1-(4-amino-2-oxopyrimidin-1(2H)-yl)-3-hydroxypropan-2-yl)oxy)methyl)phosphonic acid
More details are to be found here
Description : Cidofovir is inhibitory to CMV plaque formation even when added to the cells at 48 hr post infection with IC50 of 0.9 μg/mL for Davis and 1.6 μg/mL for AD-169 strains,respectively. - Molecular Weight :279.19
- Boiling Point :609.5±65.0°C (Predicted)
- Melting Point :260°C (dec.)
- Purity :≥98% by HPLC
Molecular Formula : C8H14N3O6P Canonical SMILES : C1=CN(C(=O)N=C1N)CC(CO)OCP(=O)(O)O InChI : InChI=1S/C8H14N3O6P/c9-7-1-2-11(8(13)10-7)3-6(4-12)17-5-18(14,15)16/h1-2,6,12H,3-5H2,(H2,9,10,13)(H2,14,15,16)/t6-/m0/s1 InChIKey : VWFCHDSQECPREK-LURJTMIESA-N Solubility : Soluble in Deionized Water (≥5 mg/mL, Warmed) Appearance : Powder Storage : Store at -20°C Synonyms : Vistide; HPMPC; (S)-HPMPC; Cidofovir anhydrous; GS-504; GS 504; GS504; (S)-1-(3-Hydroxy-2-phosphonomethoxypropyl)cytosine; (S)-(((1-(4-amino-2-oxopyrimidin-1(2H)-yl)-3-hydroxypropan-2-yl)oxy)methyl)phosphonic acid
More details are to be found here
Description : Cidofovir is inhibitory to CMV plaque formation even when added to the cells at 48 hr post infection with IC50 of 0.9 μg/mL for Davis and 1.6 μg/mL for AD-169 strains,respectively. - Molecular Weight :279.19
- Boiling Point :609.5±65.0°C (Predicted)
- Melting Point :260°C (dec.)
- Purity :≥98% by HPLC
Molecular Formula : C8H14N3O6P Canonical SMILES : C1=CN(C(=O)N=C1N)CC(CO)OCP(=O)(O)O InChI : InChI=1S/C8H14N3O6P/c9-7-1-2-11(8(13)10-7)3-6(4-12)17-5-18(14,15)16/h1-2,6,12H,3-5H2,(H2,9,10,13)(H2,14,15,16)/t6-/m0/s1 InChIKey : VWFCHDSQECPREK-LURJTMIESA-N Solubility : Soluble in Deionized Water (≥5 mg/mL, Warmed) Appearance : Powder Storage : Store at -20°C Synonyms : Vistide; HPMPC; (S)-HPMPC; Cidofovir anhydrous; GS-504; GS 504; GS504; (S)-1-(3-Hydroxy-2-phosphonomethoxypropyl)cytosine; (S)-(((1-(4-amino-2-oxopyrimidin-1(2H)-yl)-3-hydroxypropan-2-yl)oxy)methyl)phosphonic acid
More details are to be found here
Description : Cidofovir is inhibitory to CMV plaque formation even when added to the cells at 48 hr post infection with IC50 of 0.9 μg/mL for Davis and 1.6 μg/mL for AD-169 strains,respectively. - Molecular Weight :279.19
- Boiling Point :609.5±65.0°C (Predicted)
- Melting Point :260°C (dec.)
- Purity :≥98% by HPLC
Molecular Formula : C8H14N3O6P Canonical SMILES : C1=CN(C(=O)N=C1N)CC(CO)OCP(=O)(O)O InChI : InChI=1S/C8H14N3O6P/c9-7-1-2-11(8(13)10-7)3-6(4-12)17-5-18(14,15)16/h1-2,6,12H,3-5H2,(H2,9,10,13)(H2,14,15,16)/t6-/m0/s1 InChIKey : VWFCHDSQECPREK-LURJTMIESA-N Solubility : Soluble in Deionized Water (≥5 mg/mL, Warmed) Appearance : Powder Storage : Store at -20°C Synonyms : Vistide; HPMPC; (S)-HPMPC; Cidofovir anhydrous; GS-504; GS 504; GS504; (S)-1-(3-Hydroxy-2-phosphonomethoxypropyl)cytosine; (S)-(((1-(4-amino-2-oxopyrimidin-1(2H)-yl)-3-hydroxypropan-2-yl)oxy)methyl)phosphonic acid
More details are to be found here
Description : Cidofovir is inhibitory to CMV plaque formation even when added to the cells at 48 hr post infection with IC50 of 0.9 μg/mL for Davis and 1.6 μg/mL for AD-169 strains,respectively. - Molecular Weight :279.19
- Boiling Point :609.5±65.0°C (Predicted)
- Melting Point :260°C (dec.)
- Purity :≥98% by HPLC
Molecular Formula : C8H14N3O6P Canonical SMILES : C1=CN(C(=O)N=C1N)CC(CO)OCP(=O)(O)O InChI : InChI=1S/C8H14N3O6P/c9-7-1-2-11(8(13)10-7)3-6(4-12)17-5-18(14,15)16/h1-2,6,12H,3-5H2,(H2,9,10,13)(H2,14,15,16)/t6-/m0/s1 InChIKey : VWFCHDSQECPREK-LURJTMIESA-N Solubility : Soluble in Deionized Water (≥5 mg/mL, Warmed) Appearance : Powder Storage : Store at -20°C Synonyms : Vistide; HPMPC; (S)-HPMPC; Cidofovir anhydrous; GS-504; GS 504; GS504; (S)-1-(3-Hydroxy-2-phosphonomethoxypropyl)cytosine; (S)-(((1-(4-amino-2-oxopyrimidin-1(2H)-yl)-3-hydroxypropan-2-yl)oxy)methyl)phosphonic acid
More details are to be found here
Detailed information on the suppliers of
Cidofovir
|
Properties:
... more properties and specification on Cidofovir
|
|
Privileged suppliers
Last update 2024-05-13
|